[1]Tang Hailing，Fan Limei，Han Zhen，et al.Study on the correlation factors of angiogenesis in various clinical stages of hepatitis B related liver cancer［J］.Chinese Pharmacology Bulletin，2015，24(6)：882-883.［汤海玲，范丽梅，韩珍，等.乙肝相关肝癌各临床分期中血管新生相关因子的研究［J］.中国药理学通报，2015，24(6)：882-883.］
[2]Zhang Shen.Research on the effect of different capacity management programs on coagulation function in patients with primary liver cancer［J］.Chinese Journal of Medicine，2015，17(9)：893-894.［张申.不同容量管理方案对原发性肝癌手术患者凝血功能影响的研究［J］.中国医药导刊，2015，17(9)：893-894.］
[3]Li H，Xu F，Li S，et al.The tumor microenvironment：An irreplaceable element of tumor budding and epithelial-mesenchymal transition-mediated cancer metastasis［J］.Cell Adh Migr，2016，10(4)：434-446.
[4]Du Yingqiang，Wang Zhen，Chen Bingyu，et al.Effects of plasma infusion on coagulation function and liver biochemical indexes in hepatocellular carcinoma［J］.Zhejiang Medicine，2015，37(24)：2010-2012.［杜壵强，王震，陈秉宇，等.血浆输注对肝癌患者凝血功能和肝生化指标的影响［J］.浙江医学，2015，37(24)：2010-2012.］
[5]Lu Xinran，Feng Jingjian，Tan Junli，et al.Effects of TACE on coagulation function in patients with primary hepatocellular carcinoma［J］.Hebei Medicine，2014，19(6)：863-864.［鲁欣然，冯景见，檀军丽，等.TACE对原发性肝癌患者凝血功能的影响［J］.河北医药，2014，19(6)：863-864.］
[6]Nojima H，Konishi T，Freeman CM，et al.Chemokine receptors，CXCＲ1 and CXCＲ2，differentially regulate exosome release in hepatocytes［J］.PLoS One，2016，11(8)：e0161443.
[7]Qiu Jiaren.The relationship between CT and VEGF expression in primary liver cancer［J］.Chinese Journal of Integrated Chinese and Western Medicine，2015，23(5)：339-341.［裘加人.原发性肝癌CT征象与VEGF表达的关系分析［J］.中国中西医结合消化杂志，2015，23(5)：339-341.］
[8]Chen Xueli，Yang Hongqiang，Ji Rong，et al.Multifactor analysis of the correlation between hepatitis B virus infection and liver cancer［J］.Journal of Chinese Hospital Infection，2014，5(17)：4288-4289.［陈雪莉，杨宏强，季榕，等.乙型肝炎病毒感染与肝癌相关性的多因素分析［J］.中华医院感染学杂志，2014，5(17)：4288-4289.］
[9]Shen Yi'nan，Zhu Fengfeng，Wang Zhouchong，et al.New tumor markers of hepatocellular carcinoma［J］.Modern Oncology，2015，23(14)：2066-2069.［沈艺南，朱峰锋，王舟翀，等.肝癌的新型肿瘤标志物［J］.现代肿瘤医学，2015，23(14)：2066-2069.］
[10] Gao Rui，Liu Zhongjing，Chen Fei,et al.Logistic regression analysis of risk factors related to hepatitis B associated with primary hepatocellular carcinoma［J］.Journal of Clinical Hepatobiliary Disease，2014，30(4)：370-372.［高蕊，刘中景，陈菲，等.乙型肝炎相关性原发性肝癌相关危险因素的Logistic回归分析［J］.临床肝胆病杂志，2014，30(4)：370-372.］
[11]Kinoshita A，Onoda H，Imai N，et al.C-reactive protein as a prognostic marker in patients with hepatocellular carcinoma［J］.Hepatogastroenterology，2015，62(140)：966-970.
[12]Gan Yu，Tian Nana，Chen Huahui，et al.Correlation between AFP concentration and clinical characteristics and prognosis of primary hepatocellular carcinoma［J］.Journal of Chinese Cancer Prevention，2016，23(14)：958-962.［甘雨，田娜娜，陈华辉，等.原发性肝癌患者AFP浓度与临床特点及预后的相关性［J］.中华肿瘤防治杂志，2016，23(14)：958-962.］
[13]Liu Yingli，Zhang Qingyun.The relationship between the level of alpha-fetoprotein and alpha-l-dicosidase and hepatitis B virus nucleic acid and primary hepatocellular carcinoma［J］.Immunological Analysis and Clinical Analysis，2016，23(3)：241-243.［刘英丽，张青云.甲胎蛋白和α-L-岩藻糖苷酶及乙肝病毒核酸水平与原发性肝癌的关系［J］.标记免疫分析与临床，2016，23(3)：241-243.］